成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 58909-39-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 58909-39-0
Chemical Structure| 58909-39-0
Structure of 58909-39-0 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 58909-39-0 ]

Related Doc. of [ 58909-39-0 ]

Alternatived Products of [ 58909-39-0 ]
Product Citations

Product Details of [ 58909-39-0 ]

CAS No. :58909-39-0 MDL No. :MFCD00185756
Formula : C4H5N3O2S Boiling Point : -
Linear Structure Formula :- InChI Key :UMWWHOXOVPIGFD-UHFFFAOYSA-N
M.W : 159.17 Pubchem ID :3034640
Synonyms :

Calculated chemistry of [ 58909-39-0 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 37.77
TPSA : 102.74 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.55 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.41
Log Po/w (XLOGP3) : -0.39
Log Po/w (WLOGP) : -0.87
Log Po/w (MLOGP) : -0.9
Log Po/w (SILICOS-IT) : 1.91
Consensus Log Po/w : 0.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.03
Solubility : 15.0 mg/ml ; 0.0944 mol/l
Class : Very soluble
Log S (Ali) : -1.3
Solubility : 7.9 mg/ml ; 0.0497 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.76
Solubility : 28.0 mg/ml ; 0.176 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.13

Safety of [ 58909-39-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 58909-39-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 58909-39-0 ]

[ 58909-39-0 ] Synthesis Path-Downstream   1~13

  • 1
  • [ 58909-39-0 ]
  • [ 95672-05-2 ]
  • [ 116536-09-5 ]
  • 2
  • [ 58909-39-0 ]
  • [ 143731-84-4 ]
  • [ 119742-06-2 ]
  • 3
  • [ 58909-39-0 ]
  • [((6R,7S)-3-Chloromethyl-7-ethyl-5,5,8-trioxo-5λ6-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carbonyl)-methyl-amino]-acetic acid tert-butyl ester [ No CAS ]
  • [(6R,7S)-7-Ethyl-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-5,5,8-trioxo-5λ6-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carbonyl]-methyl-amino}-acetic acid tert-butyl ester [ No CAS ]
  • 4
  • [ 58909-39-0 ]
  • [ 116536-11-9 ]
  • [ 116536-14-2 ]
  • 5
  • [ 58909-39-0 ]
  • 3-[((6R,7S)-3-Chloromethyl-7-methoxy-5,5,8-trioxo-5λ6-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carbonyl)-methyl-amino]-propionic acid tert-butyl ester [ No CAS ]
  • 3-[(6R,7S)-3-(6-Hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-7-methoxy-5,5,8-trioxo-5λ6-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carbonyl]-methyl-amino}-propionic acid tert-butyl ester [ No CAS ]
  • 6
  • [ 58909-39-0 ]
  • (S)-1-((6R,7S)-3-Chloromethyl-7-methoxy-5,5,8-trioxo-5λ6-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carbonyl)-pyrrolidine-2-carboxylic acid tert-butyl ester [ No CAS ]
  • (S)-1-[(6R,7S)-3-(6-Hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-7-methoxy-5,5,8-trioxo-5λ6-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carbonyl]-pyrrolidine-2-carboxylic acid tert-butyl ester [ No CAS ]
  • 7
  • [ 58909-39-0 ]
  • [ 138810-38-5 ]
  • 4-(tert-butylcarbonyl)-2α-<6-(hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio>-7α-methoxy-3-methyl-Δ3-cephem 1,1-dioxide [ No CAS ]
  • 8
  • sodium salt of ceftriaxone [ No CAS ]
  • [ 58909-39-0 ]
  • (6R,7S)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid anion [ No CAS ]
  • [ 153470-19-0 ]
  • 9
  • (6R,7S)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid anion [ No CAS ]
  • [ 58909-39-0 ]
  • sodium salt of ceftriaxone [ No CAS ]
  • C14H13N5O6S2(2-) [ No CAS ]
  • 10
  • [ 60846-21-1 ]
  • [ 58909-39-0 ]
  • [ 73384-59-5 ]
YieldReaction ConditionsOperation in experiment
With sodium acetate; In methanol; dichloromethane; water; Ceftriaxone-One Pot Procedure 23.87 g of cefotaxime in free form and 7.95 g of 3-mercapto-2-methyl-(2,5-dihydro-6-hydroxy-5-oxo-as)-triazin in 150 ml of dichloromethane are treated with 57.92 g of BSTFA while stirring under inert gas. A solution obtained is refluxed for several hours, cooled in an ice-bath, and treated with 33.34 g of TMSTf. The mixture obtained is poured onto an ice-cooled solution of 20.5 g of sodium acetate in 350 ml of methanol/water and 250 ml of water and 500 ml of dichloromethane are added. Further treatment and work-up is carried out according to the method describred in example 8. Disodium ceftriaxone is obtained in a purity of 99.6% (HPLC, area).
YieldReaction ConditionsOperation in experiment
[A] 3-Mercapto-2,5-dihydro-2-methyl-5-oxo-6-hydroxy -1,2,4-triazine NMR(D2 O)delta; 3.43(2H,ABq), 3.69(3H,s), 4.22(2H,ABq), 5.16(lH,d), 5.33(2H,ABq), 5.82(lH,d), 6.86(lH,s), 7.11(lH,s), 7.74(lH,s)
(A) 3-Mercapto-2,5-dihydro-2-methyl-5-oxo-6-hydroxy-1,2,4-triazine NMR(D2 O) delta: 3.50(1/2*2H, ABq), 3.58(1/2*2H, ABq), 3.65, 3.66(each 1/2*3H, s), 4.21(1/2*2H, ABq), 4.24(1/2*2H, ABq), 5.04(1H, s), 5.10(1/2H, d), 5.14(1/2H, d), 5.63(1/2H, d), 5.72(1/2H, d), 6.75(1/2H, s), 6.80(1/2H, s), 7.35(1/2H, s), 7.36(1/2H, s), 7.58(1H, s).
  • 12
  • [ 58909-39-0 ]
  • [ 58479-61-1 ]
  • 6-((tert-butyldiphenylsilyl)oxy)-3-mercapto-2-methyl-1,2,4-triazin-5(2H)-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In tetrahydrofuran; (A) A solution of 2-methyl-3-mercapto-6-hydroxy-2,5-dihydro-1,2,4-triazin-5-one (0.8 g) in dry tetrahydrofuran (25 ml) was stirred for 30 min with triethylamine (0.835 ml) and tert-butyldiphenylsilylchloride (1.53 ml). The reaction mixture was partitioned between 1% aqueous NaHCO3 and ethyl acetate. Removal of the solvent from the dried organic layer left a residue which crystallized by trituration with light petrol affording 2-methyl-3-mercapto-6-tert-butyldiphenylsilyloxy-2,5-dihydro-1,2,4-triazin-5-one (1.34 g), m.p. 135 C. (decomp.). UV (CHCl3) lambdamax: 276 (epsilon=20,820) and 320 sh (=4,460) nm. IR (CHCl3) gammamax 1720, 1580 cm-1. NMR (CDCl3) deltappm: 1.1 (9H, s), 3.4 (3H, s), 7.2-7.7 (10H, m), 9.9 (1H, br s).
  • 13
  • 3-iodomethyl-3-cephem [ No CAS ]
  • 7β-[2-(2-Aminothiazol-4-yl)-(4-chlorobenzyloxyimino)acetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid [ No CAS ]
  • [ 58909-39-0 ]
  • 7β-[2-(2-Aminothiazol-4-yl)-2-(4-chlorobenzyloxyimino)acetamido]-3-[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl)thiomethyl]-3-cephem-4-carboxylic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
With TMSI; acetic acid; In tetrahydrofuran; dichloromethane; water; dimethyl sulfoxide; acetonitrile; EXAMPLE 2 7beta-[2-(2-Aminothiazol-4-yl)-2-(4-chlorobenzyloxyimino)acetamido]-3-[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl)thiomethyl]-3-cephem-4-carboxylic acid To a suspension of 200 mg (0.35 mmole) of 7beta-[2-(2-aminothiazol-4-yl)-2-(4-chlorobenzyloxyimino)acetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid in 5 ml of methylene chloride was added 0.5 ml of MSTFA and the suspension was stirred at 40 C. until solution occurred. The solution was cooled to room temperature and 0.13 ml (0.87 mmole) of TMSI was added. The reaction stirred at room temperature for 30 minutes and evaporated to an oil. The oil was dissolved in 3 ml of acetonitrile and 0.12 ml (1.5 mmole) of THF was added. The mixture was then stirred at room temperature for 5 minutes to destroy excess TMSI and provide in solution the corresponding 3-iodomethyl-3-cephem derivative. To the solution of the 3-iodomethyl-3-cephem was added a solution of 65 mg (0.4 mmole) of 2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazine-3-thiol in 1 ml of acetonitrile, prepared with 0.25 ml of MSTFA, and the mixture was stirred at room temperature for 3 hours. The reaction mixture then was treated with three drops of water, the precipitate filtered and dried to yield 240 mg of crude title compound. The product was dissolved in DMSO and chromatographed over a C18 reverse phase column using 30% acetonitrile:water:2% acetic acid for elution. The fractions containing the product were combined, concentrated to a small volume by evaporation, and the concentrate lyophilized to yield 100 mg of the title compound. IR: 1772 cm-1 (beta-lactam carbonyl). UV: lambdamax 225 epsilon29855. MS (FAB): M+ 665.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 58909-39-0 ]

Amides

Chemical Structure| 117829-36-4

[ 117829-36-4 ]

3-Amino-2-thioxoimidazolidin-4-one

Similarity: 0.80

; ;